Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Celldex Therapeutics (CLDX)

Add to Watchlists
Create an Alert
15.47 -0.54  -3.37% NASDAQ Apr 23, 10:38AM BATS Real time Currency in USD
View Full Chart
CLDX Price Chart
View All Events

CLDX Events

Date Type Description
Mar 03 Misc Celldex Therapeutics, Inc. Q4 2013 Earnings Conference Call
Mar 03 Earnings Celldex Therapeutics, Inc. Q4 2013 Earnings Results. Estimate: -0.28.
Nov 08 Earnings Celldex Reports Third Quarter 2013 Financial Results. Estimate: -0.24.
Nov 07 Misc Celldex Reports Third Quarter 2013 Financial Results Conference Call
Aug 06 Earnings Celldex Reports Second Quarter 2013 Financial Results. Estimate: -0.22.
Jun 12 Misc AGM Event for Celldex Therapeutics Inc.
View All Performance Charts

CLDX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Celldex Therapeutics is up 18.91% over the last year vs S&P 500 Total Return up 22.70%, Array BioPharma down 38.26%, and Alexion Pharmaceuticals up 69.15%.

Get Quote for

PDF Report for CLDX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download CLDX Pro Report PDF

Portfolio Strategies Featuring CLDX

Did Celldex Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CLDX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Celldex Therapeutics, Inc., is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CLDX 15.47 -0.54 -3.37% 1.381B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.